This paper highlights the emotional and social aftermath of colectomy and J‑pouch surgery for people with ulcerative colitis, a topic that directly affects patients facing or living with these procedures.

The analysis suggests that placebo arms in Phase 3 IBD trials are associated with higher rates of serious events, mainly disease exacerbations; this matters because it raises ethical and safety concerns for people with...

If validated in clinical studies, extending the interval between subcutaneous vedolizumab doses could reduce injection frequency, costs, and treatment burden for some patients on maintenance therapy.

Early, noninvasive biomarkers could help detect ulcerative colitis and related colorectal cancer risk sooner. This study identifies four serum-accessible proteins with promising diagnostic accuracy in the reported...

If your inflammatory back pain involves both upper and lower spine early on, this study suggests you may have a higher chance of developing peripheral arthritis later — information that could affect monitoring and...

This review explains mechanisms by which gut inflammation can reprogram bone marrow and innate immunity, a process that may help explain persistent inflammation and risks like colitis-associated cancer. Understanding...

This trial directly informs a common clinical question: whether patients in deep remission can safely stop anti‑TNF therapy. Results show higher relapse risk after withdrawal, but many patients can be successfully...

This study describes a new plant-derived nanoparticle (EBDEVs) that reduced inflammation and improved colon health in a mouse model of ulcerative colitis and altered the gut microbiota — early evidence that may guide...

The study proposes a targeted oral delivery method that could help concentrate anti-inflammatory natural compounds at inflamed colon sites, potentially improving treatment effectiveness for ulcerative colitis while...

Antibiotics commonly used against anaerobes affected opportunistic IBD-associated strains and beneficial commensals differently in lab cultures; this could influence thinking about using broad‑spectrum antibiotics to...

CVID can cause GI problems that closely mimic Crohn’s disease, ulcerative colitis, or celiac disease and may change diagnostic and treatment choices. Gastroenterologists need to consider CVID when IBD presentations are...

A new Phase 2 trial is testing whether intravenous allogeneic HB-adMSCs can improve Crohn’s symptoms and intestinal inflammation. If effective and safe, the therapy could offer a different mechanism of treatment from...

Weight loss before or around colectomy/IPAA could affect surgical risk and recovery; this study tests an endoscopic, non‑surgical weight‑loss procedure specifically in people with ulcerative colitis who are planning...

A new investigational drug (BI 3032950) is being tested specifically for people with ulcerative colitis who did not do well on prior biologic or targeted treatments. If effective and safe, it could become another option...

This trial tested a rectal hydrocortisone formulation specifically for ulcerative proctitis, a form of ulcerative colitis limited to the rectum. If effective and safe, a local steroid suppository could offer targeted...

Patients on anti-TNF biologics often seek safe ways to support gut microbial health. This trial tests a prebiotic supplement (2'-FL) for safety and whether it increases beneficial bacteria and butyrate in young people...

People with Crohn’s disease who are overweight or have obesity may have different disease and treatment needs. This Phase 3 trial is testing whether adding tirzepatide to mirikizumab improves both disease outcomes and...

Bowel urgency is a common, distressing symptom in ulcerative colitis; a minimally invasive implant that reduces urgency could improve daily functioning and quality of life if proven effective and safe.

Cure8 could only read part of this source from health.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Symptoms and flares.

Mental health problems often begin before IBD is diagnosed and stay higher for years after; addressing psychiatric symptoms early could improve overall disease management and quality of life for people with Crohn’s...

The study reports a novel nanoparticle method to deliver curcumin specifically to inflamed colon tissue, which in mice improved gut inflammation, microbiome balance, barrier repair, and depression‑like behaviors—areas...

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease and Pregnancy and fertility. The original article is from hmpgloballearningnetwork.com.

A genetic marker (HLA-DRB1*01:03) was linked to more severe IBD outcomes—higher rates of colectomy/colonic surgery, more perianal disease, earlier use and higher failure of advanced therapies—which could help explain...

This work describes a novel engineered probiotic designed to survive the gastrointestinal tract and act specifically at inflamed colitis sites, which could lead to new targeted therapies for IBD if validated in humans.

People with Crohn’s disease on ustekinumab may be more likely to need intensified dosing if they previously tried biologics or immunomodulators or have had disease longer; this could affect monitoring and planning. For...

Surgical choices for ulcerative colitis—permanent ileostomy versus ileal pouch (IPAA)—lead to very different daily-life outcomes. Understanding risks and lifestyle tradeoffs and using shared decision-making helps...

Immigrants with IBD reported substantial barriers to care — language gaps, work-related limits on attending appointments, and cultural concerns — which can hinder disease management. Recognizing these issues can help...

Depression and suicide are important concerns for people with IBD. This study shows higher hospitalization risk for depression in IBD but a decline in those hospitalizations over time, which may reflect changing care...

Standardized CCPs aim to improve consistency and quality of IBD care nationwide; nationalizing 16 CCPs could help reduce regional variation and support clinicians and patients in Canada.

Endoscopy comfort and sedation differ between pediatric and adult settings, and worse adult experiences could deter young adults from needed surveillance or care. Addressing sedation choice, communication, and provider...

Adolescents with IBD often experience abdominal pain that affects daily life. This study suggests psychological resilience — especially optimism and mindfulness — is linked with less pain, pointing to nonpharmacologic...

The study suggests people with Crohn's disease or ulcerative colitis have higher lipoprotein(a) levels than healthy controls, which could be relevant because Lp(a) is a cardiovascular-risk biomarker and cardiovascular...

IOIBD’s consensus frameworks and educational programs shape how IBD is studied and treated worldwide — affecting trial design, treatment goals, patient-reported outcome measures, and clinical guidance that patients and...

Strongyloides infection can look like IBD on symptoms and endoscopy/biopsy; missing it and giving immunosuppressants risks severe, potentially life-threatening hyperinfection. Recognizing this overlap helps avoid...

Based on the title and source metadata, this appears to be a case report related to Ulcerative colitis, Inflammatory bowel disease, and Genetics and genomics. The original article is from Cureus.

A probe that images superoxide in inflamed colons could help researchers study oxidative stress in ulcerative colitis and potentially guide development of new biomarkers or imaging approaches.

This study highlights that people who go on to develop myasthenia gravis had higher rates of other autoimmune diagnoses in the years beforehand, which may be relevant for clinicians tracking autoimmune comorbidity...

Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...

If approved, a vedolizumab biosimilar could increase treatment options and competitive pricing for adults with moderate-to-severe ulcerative colitis or Crohn's disease. The company already markets a natalizumab...

Based on the title and source metadata, this appears to be a case report related to Crohn's disease, JAK inhibitor, and Medications. The original article is from cureus.com.

If you are Ashkenazi Jewish or care for someone who is, research shows higher group-level risk for Crohn’s disease, ulcerative colitis and lactose intolerance—so awareness and early evaluation for gut symptoms may be...

The study suggests a combined probiotic-plus-nutrient approach may improve intestinal barrier integrity, reduce inflammation, and restore epithelial metabolism in an IBD model—areas not fully addressed by current...

Researchers tested a ginger-derived glucan that reduced inflammation and reshaped the gut microbiota in a mouse colitis model — a potential prebiotic approach that could inform future IBD therapies or dietary strategies.

This paper suggests that epithelial barrier structure and function may be altered in very early onset pediatric IBD. That could help researchers study disease mechanisms and eventually guide targeted therapies for...

PSC occurring with IBD changes cancer risk and surveillance needs: patients can have extensive but asymptomatic colitis and a higher colorectal and biliary cancer risk. The review outlines gaps in diagnosis, monitoring,...

The review links macrophage-driven repair mechanisms to chronic inflammation and fibrosis in autoimmune diseases, including IBD, and highlights experimental strategies that aim to promote resolution rather than suppress...

The microbiome is increasingly viewed as an influence on IBD development and persistence, and microbiome-directed therapies (like FMT and engineered bacteria) are an active area of research that could one day add to...

This study reports a new colon-targeted delivery system for unconjugated bilirubin that reduced inflammation and improved mucosal healing in a mouse model of ulcerative colitis; it could inform future drug-development...